Association of Sodium-Glucose Cotransporter 2 Inhibitor vs Dipeptidyl Peptidase-4 Inhibitor Use With Risk of Incident Obstructive Airway Disease and Exacerbation Events Among Patients With Type 2 Diabetes in Hong Kong

IMPORTANCE: Patients with diabetes are at higher risk for obstructive airway disease (OAD). In recent meta-analyses of post hoc analyses of cardiorenal trials, sodium-glucose cotransporter 2 inhibitors (SGLT2Is) were suggested to reduce the risk of OAD adverse events. However, a clinical investigati...

Descripción completa

Detalles Bibliográficos
Autores principales: Au, Philip C. M., Tan, Kathryn C. B., Lam, David C. L., Cheung, Bernard M. Y., Wong, Ian C. K., Kwok, Wang Chun, Sing, Chor-Wing, Cheung, Ching-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857182/
https://www.ncbi.nlm.nih.gov/pubmed/36648944
http://dx.doi.org/10.1001/jamanetworkopen.2022.51177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857182/
https://www.ncbi.nlm.nih.gov/pubmed/36648944
http://dx.doi.org/10.1001/jamanetworkopen.2022.51177

Ejemplares similares